Evaluating the immunogenicity of clade 2 and clade 3 sarbecovirus spike protein nanoparticle vaccines in Syrian hamsters. Halfmann PJ, Duffy A, Wang T, Kawaoka Y, et al. Vaccine 2026;84:128653.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Halfmann PJ, Duffy A, Wang T, Kawaoka Y, et al. Evaluating the immunogenicity of clade 2 and clade 3 sarbecovirus spike protein nanoparticle vaccines in Syrian hamsters. Vaccine 2026;84:128653.
PMID: 42114416